Meningococcal B Vaccination (4CMenB) in Infants and Toddlers
Abstract
Neisseria meningitidis is a Gram-negative pathogen that actively invades its human host and leads to the development of life-threatening pathologies. One of the leading causes of death in the world, N. meningitidis can be responsible for nearly 1,000 new infections per 100,000 subjects during an epidemic period. The bacterial species are classified into 12 serogroups, five of which (A, B, C, W, and Y) cause the majority of meningitides. The three purified protein conjugate vaccines currently available target serogroups A, C, W, and Y. Serogroup B has long been a challenge but the discovery of the complete genome sequence of an MenB strain has allowed the development of a specific four-component vaccine (4CMenB). This review describes the pathogenetic role of N. meningitidis and the recent literature concerning the new meningococcal vaccine.
References
Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines
Citations
YraP Contributes to Cell Envelope Integrity and Virulence of Salmonella enterica Serovar Typhimurium
Methods Mentioned
Related Concepts
Related Feeds
Bacterial Meningitis
Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.
Bacterial Meningitis (ASM)
Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.